Tenet Healthcare (THC) CIO granted 18,894 performance-based shares

Rhea-AI Filing Summary

TENET HEALTHCARE CORP executive Paola M. Arbour, EVP and Chief Information Officer, reported acquiring 18,894 shares of common stock through a grant or award on February 13, 2026. The shares were issued at a stated price of $0.0000 per share, bringing her directly held total to 39,004 shares.

According to the disclosure, this grant represents performance-based restricted stock that was earned when the company’s Human Resources Committee certified that applicable performance targets were achieved for the performance period from January 1, 2023 to December 31, 2025.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Arbour Paola M

Role EVP, Chief Information Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,894	$0.00	--

Holdings After Transaction: Common Stock — 39,004 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arbour Paola M

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		A(1)		18,894	A	$0	39,004	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2023 to December 31, 2025.

	Chad J. Wiener, as Attorney-in-fact for Paola M. Arbour	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paola M. Arbour report in this Form 4 for THC?

Paola M. Arbour reported acquiring 18,894 shares of Tenet Healthcare common stock through a grant or award. The shares increased her directly held position to 39,004 shares and reflect performance-based restricted stock earned after performance goals were certified.

How many Tenet Healthcare (THC) shares did the EVP CIO acquire?

She acquired 18,894 shares of Tenet Healthcare common stock. This transaction was reported as a grant or award with a stated price of $0.0000 per share, raising her directly owned holdings to 39,004 shares after the award.

What kind of equity award did Paola Arbour receive from Tenet Healthcare (THC)?

She received a grant of performance-based restricted stock that was earned upon certification of performance targets. The award reflected the extent to which applicable performance goals were attained over a defined multi-year performance period ending December 31, 2025.

What performance period applied to Paola Arbour’s THC stock award?

The performance-based restricted stock related to a performance period from January 1, 2023 to December 31, 2025. The Human Resources Committee certified achievement of applicable performance targets for that period before the award was earned and reflected in the Form 4.

Does this Tenet Healthcare (THC) Form 4 show a stock sale by Paola Arbour?

No, the Form 4 reports an acquisition via grant or award, not a sale. The transaction code is A, which denotes a grant, award, or other acquisition, and it increased her directly held common stock position at no stated purchase price.

What is Paola Arbour’s role at Tenet Healthcare (THC) mentioned in the filing?

She is identified as Executive Vice President and Chief Information Officer of Tenet Healthcare. The Form 4 links this officer role to the reported performance-based restricted stock grant that increased her directly owned common stock holdings.